AbbVie
ABBV
#29
Rank
S$625.54 B
Marketcap
S$353.99
Share price
1.49%
Change (1 day)
18.36%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Net assets

Net assets on the balance sheet as of June 2026 : -S$7.54 Billion

According to AbbVie's latest financial reports the company has -S$7.54 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

AbbVie - Net assets on balance sheet (from 2011 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$-S$4.15 Billion-190.64%
2024-12-31$S$4.57 B-66.7%
2023-12-31$S$13.73 B-40.75%
2022-12-31$S$23.17 B11.05%
2021-12-31$S$20.86 B20.44%
2020-12-31$S$17.32 B-257.27%
2019-12-31$-S$11.02 Billion-4.52%
2018-12-31$-S$11.54 Billion-269.25%
2017-12-31$S$6.81 B1.6%
2016-12-31$S$6.70 B20.24%
2015-12-31$S$5.58 B142.44%
2014-12-31$S$2.30 B-59.56%
2013-12-31$S$5.69 B38.39%
2012-12-31$S$4.11 B-73.39%
2011-12-31$S$15.45 B-23.61%
2010-12-31$S$20.22 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
S$109.46 B-1,551.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$43.37 B-675.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$14.96 B-298.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$24.13 B-420.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$15.03 B-299.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$28.57 B-479.06%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$64.49 B-955.47%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$29.14 B-486.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
S$4.72 B-162.73%๐Ÿ‡บ๐Ÿ‡ธ USA